Cardiac Pacemaker Development
心脏起搏器开发
基本信息
- 批准号:8237943
- 负责人:
- 金额:$ 38.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-02 至 2016-11-30
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsArrhythmiaArtificial cardiac pacemakerCardiacCardiac MyocytesCardiovascular systemCell Differentiation processCellsCharacteristicsCollaborationsDataDefectDevelopmentEmbryoEmbryonic DevelopmentExhibitsFutureGenerationsGenesGrowthHeartHeart DiseasesHumanImageIn Situ HybridizationIn VitroIon ChannelLateralLateral MesodermLeadLifeLocationMapsMediatingMesodermMesoderm CellMolecularMonitorMorbidity - disease rateOpticsPacemakersPathway interactionsPatternPhysiologicalPopulationPrevalenceProductionProtocols documentationRNAResearchReverse Transcriptase Polymerase Chain ReactionRoleSignal TransductionSinoatrial NodeSiteSpecific qualifier valueStagingTechniquesTestingTherapeuticTimeTissue EngineeringTissuesTubeViralbasecardiogenesiscell fate specificationcell typeeffective therapyembryo tissuein vivoion channel blockermortalitynodal myocytenovelprecursor cellrepairedserial analysis of gene expression
项目摘要
DESCRIPTION (provided by applicant): Cardiac pacemaker cells of the Sinoatrial Node are essential for producing rhythmic heartbeats. Despite the importance of this specialized cardiac cell type, little is known about their ontogeny or mechanisms of specification and differentiation. Our preliminary data show that although the primary heart tube initially displays rhythmic beating, the cells pacing it do not differentiate into the Sinoatrial Node. Instead, pacemaker precursors arise from the mesoderm posterior to the known cardiogenic field and take over the pacing function during heart-looping. Surprisingly, the pacemaker precursor mesoderm can differentiate in culture without any other surrounding embryonic tissues. They display sustained rhythmic beat rates, and sensitivity to pacemaker cell specific ion channel blockers. Furthermore, they have the ability to pace other cardiomyocyte populations. Our global RNA profiling has identified a unique set of Wnt-related genes expressed in pacemaker precursors. These somewhat surprising findings lead to three central hypotheses: (1) the pacemaker precursors arise from a specific mesoderm population separate from the heart field; (2) pacemaker cell fate is induced prior to heart tube formation; and (3) Wnt-related signaling, which is inhibitory to the heart field, acts as a promoting signal during pacemaker cell specification. We will test these hypotheses experimentally. This proposal will provide the first basis for identifying the embryonic origin of pacemaker precursors (Aim 1), the ability of a specific mesoderm subpopulations to enter the pacemaker cell fate (Aim 2), and novel molecular mechanisms that specify and direct the differentiation this important cell type during a brief temporal window and at a defined site in the embryo (Aim 3).
PUBLIC HEALTH RELEVANCE: The cardiac pacemaker is essential for cardiac function and survival. Limited options of effective treatments contribute to the continued prevalence of arrhythmic heart disease. The proposed study will explore the molecular mechanisms that regulate the earliest developmental steps leading to the generation of this essential cardiac tissue and may provide a basis for future therapeutic approaches.
描述(由申请人提供):Sinoatrial节点的心脏起搏器细胞对于产生有节奏的心跳至关重要。尽管这种专门的心脏细胞类型很重要,但对它们的本体发育或规范和分化机制知之甚少。我们的初步数据表明,尽管主要心脏管最初显示节奏的跳动,但其起搏的细胞并未区分到弦乐节点中。取而代之的是,起搏器前体来自中胚层后部到已知的心源场,并在心摇动过程中接管起搏功能。令人惊讶的是,起搏器前体中胚层可以在培养中分化,而无需任何其他周围的胚胎组织。它们显示出持续的节奏节拍率,以及对起搏器特异性离子通道阻滞剂的敏感性。此外,它们具有加快其他心肌细胞种群的能力。我们的全球RNA分析确定了在起搏器前体中表达的一组独特的WNT相关基因。这些令人惊讶的发现导致了三个中心假设:(1)起搏器前体是由特定的中胚层种群与心脏场分开的。 (2)在心管形成之前诱导起搏器细胞命运; (3)与心脏场抑制性WNT相关的信号传导在起搏器细胞规范过程中充当促进信号。我们将通过实验测试这些假设。该提案将提供第一基础,以识别起搏器前体的胚胎起源(AIM 1),特定的中胚层亚群进入起搏器细胞命运(AIM 2)的能力以及在短暂的时间窗口和胚胎中定义的位点指定和指导这种重要细胞类型的新型分子机制(AIM 2)。
公共卫生相关性:心脏起搏器对于心脏功能和生存至关重要。有效治疗的有限选择导致心律不齐心脏病的持续患病率。拟议的研究将探索调节最早的发育步骤的分子机制,从而导致这种基本心脏组织的产生,并可能为将来的治疗方法提供基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Takashi Mikawa其他文献
Takashi Mikawa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Takashi Mikawa', 18)}}的其他基金
Development of Vascular Smooth Muscle Stem Cell Niche
血管平滑肌干细胞生态位的开发
- 批准号:
10198034 - 财政年份:2019
- 资助金额:
$ 38.63万 - 项目类别:
Development of Vascular Smooth Muscle Stem Cell Niche
血管平滑肌干细胞生态位的开发
- 批准号:
10447576 - 财政年份:2019
- 资助金额:
$ 38.63万 - 项目类别:
相似国自然基金
TMEM30a在致心律不齐性右心室心肌病中的作用及机制研究
- 批准号:82100367
- 批准年份:2021
- 资助金额:20 万元
- 项目类别:青年科学基金项目
人参抗心律不齐活性成分及其构效关系的研究*3
- 批准号:28970070
- 批准年份:1989
- 资助金额:2.5 万元
- 项目类别:面上项目
相似海外基金
Integration of structure and signaling in cardiac pacemaker function
心脏起搏器功能中结构和信号的整合
- 批准号:
8597835 - 财政年份:2013
- 资助金额:
$ 38.63万 - 项目类别:
Integration of structure and signaling in cardiac pacemaker function
心脏起搏器功能中结构和信号的整合
- 批准号:
8704998 - 财政年份:2013
- 资助金额:
$ 38.63万 - 项目类别: